| scholarly article | Q13442814 |
| P356 | DOI | 10.1167/IOVS.03-0038 |
| P698 | PubMed publication ID | 12882811 |
| P2093 | author name string | Diego G Espinosa-Heidmann | |
| Eleut P Hernandez | |||
| Scott W Cousins | |||
| Karl G Csaky | |||
| Ivan J Suner | |||
| Dagoberto Monroy | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| neovascularization | Q1281049 | ||
| P304 | page(s) | 3586-3592 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
| P1476 | title | Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization | |
| P478 | volume | 44 |
| Q33381492 | (Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system |
| Q35896752 | A Mouse Model for Laser-induced Choroidal Neovascularization |
| Q34797862 | A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis |
| Q38663964 | A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration. |
| Q24523983 | A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration |
| Q41463688 | A novel endothelial-derived anti-inflammatory activity significantly inhibits spontaneous choroidal neovascularisation in a mouse model |
| Q33802916 | A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures |
| Q57480658 | Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells |
| Q38582381 | Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward |
| Q34791186 | Age-dependent changes in FasL (CD95L) modulate macrophage function in a model of age-related macular degeneration |
| Q36909934 | Age-related macular degeneration and the immune response: implications for therapy |
| Q37577435 | Age-related macular degeneration: experimental and emerging treatments |
| Q37315838 | Aging is not a disease: distinguishing age-related macular degeneration from aging |
| Q58774090 | Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV) |
| Q35855800 | An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. |
| Q37093590 | Angiogenesis in eye disease: immunity gained or immunity lost? |
| Q35912788 | Angiopoietin-like Protein 2 Is a Multistep Regulator of Inflammatory Neovascularization in a Murine Model of Age-related Macular Degeneration |
| Q33582933 | Animal models of choroidal and retinal neovascularization |
| Q36673663 | Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases |
| Q92189844 | Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy |
| Q33449191 | Association of superoxide anions with retinal pigment epithelial cell apoptosis induced by mononuclear phagocytes |
| Q42632625 | Association of systemic steroids and mycophenolate mofetil as rescue therapy for uveitic choroidal neovascularization unresponsive to the traditional immunosuppressants: interventional case series |
| Q37940594 | Autoimmunity and age-related macular degeneration: a review of the literature. |
| Q52668524 | B-cell leukemia/lymphoma 10 promotes angiogenesis in an experimental corneal neovascularization model. |
| Q37879155 | Bevacizumab and neovascular age related macular degeneration: pathogenesis and treatment |
| Q88579538 | Blockade of TREM-1 prevents vitreoretinal neovascularization in mice with oxygen-induced retinopathy |
| Q98384539 | Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease |
| Q42992158 | Brief exposure to damaging light causes focal recruitment of macrophages, and long-term destabilization of photoreceptors in the albino rat retina. |
| Q37815237 | CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration |
| Q35028401 | CD200R signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization |
| Q42770007 | Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitis |
| Q47097580 | Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration |
| Q36105818 | Choroidal Neovascularization Is Inhibited in Splenic-Denervated or Splenectomized Mice with a Concomitant Decrease in Intraocular Macrophage |
| Q35823694 | Choroidal neovascularization is inhibited via an intraocular decrease of inflammatory cells in mice lacking complement component C3. |
| Q42328244 | Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration |
| Q43819768 | Clinical outcomes after switching treatment from intravitreal ranibizumab to aflibercept in neovascular age-related macular degeneration |
| Q61797924 | Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina |
| Q97549843 | Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice |
| Q37321510 | Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort |
| Q37413669 | Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands |
| Q38511670 | Control of the blood-brain barrier function in cancer cell metastasis |
| Q35166644 | Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. |
| Q47964831 | Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK. |
| Q28473117 | Defects in actin dynamics lead to an autoinflammatory condition through the upregulation of CXCL5 |
| Q34368177 | Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages |
| Q35908535 | Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration |
| Q35008752 | Differences in the distribution, phenotype and gene expression of subretinal microglia/macrophages in C57BL/6N (Crb1 rd8/rd8) versus C57BL6/J (Crb1 wt/wt) mice |
| Q42040053 | Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization |
| Q37397681 | Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration |
| Q47202861 | Diverse roles of macrophages in intraocular neovascular diseases: a review. |
| Q41298547 | Drusen and Pro-inflammatory Mediators in the Post-Mortem Human Eye. |
| Q79083732 | Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss? |
| Q34840091 | Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light |
| Q49223224 | Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration |
| Q46451434 | Effects of Phenotype of Retinal Macrophages on the Features of Angiogenesis of Murine Retina. |
| Q35441276 | Endothelial TWIST1 promotes pathological ocular angiogenesis. |
| Q36318186 | Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages |
| Q96431365 | Essential Contribution of Macrophage Tie2 Signalling in a Murine Model of Laser-Induced Choroidal Neovascularization |
| Q36862946 | Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages |
| Q33790460 | Evaluation of Aflibercept Treatment Responses in Eyes with Bevacizumab/Ranibizumab-resistant Wet Age-related Macular Degeneration |
| Q33882331 | Evaluation of variants in the selectin genes in age-related macular degeneration |
| Q37619593 | Eyeballing cholesterol efflux and macrophage function in disease pathogenesis |
| Q35188790 | Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy |
| Q33752902 | Gene delivery to mitotic and postmitotic photoreceptors via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosa |
| Q83524736 | High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis |
| Q28544955 | IKK2 inhibition using TPCA-1-loaded PLGA microparticles attenuates laser-induced choroidal neovascularization and macrophage recruitment |
| Q37031844 | IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis |
| Q38719578 | Identification of different macrophage subpopulations with distinct activities in a mouse model of oxygen-induced retinopathy. |
| Q41192179 | Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy |
| Q36086191 | Immunological factors in the pathogenesis and treatment of age-related macular degeneration |
| Q37109989 | Immunological mechanisms in the pathogenesis of diabetic retinopathy |
| Q37614752 | Immunology of age-related macular degeneration |
| Q36739706 | Immunopathological aspects of age-related macular degeneration |
| Q58760726 | Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss |
| Q36636094 | Increased VEGF-A promotes multiple distinct aging diseases of the eye through shared pathomechanisms |
| Q37489920 | Inflammation and the pathogenesis of age-related macular degeneration. |
| Q50648152 | Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach. |
| Q35755942 | Inflammatory Mechanisms of Age-related Macular Degeneration |
| Q37792817 | Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications |
| Q40218186 | Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos. |
| Q35947868 | Inhibition of development of laser-induced choroidal neovascularization with suppression of infiltration of macrophages in Smad3-null mice |
| Q41981791 | Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. |
| Q33285746 | Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization |
| Q35684611 | Intravitreal TSG-6 suppresses laser-induced choroidal neovascularization by inhibiting CCR2+ monocyte recruitment |
| Q35081925 | Intravitreal injection of (99)Tc-MDP inhibits the development of laser-induced choroidal neovascularization in rhesus monkeys |
| Q34557890 | JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration. |
| Q34122564 | Lack of thrombospondin 1 and exacerbation of choroidal neovascularization |
| Q35020040 | Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. |
| Q37185228 | MCP-1 deficiency delays regression of pathologic retinal neovascularization in a model of ischemic retinopathy |
| Q33857403 | MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium |
| Q34263026 | Macrophage activation associated with chronic murine cytomegalovirus infection results in more severe experimental choroidal neovascularization |
| Q33802153 | Macrophage roles following myocardial infarction |
| Q41441590 | Macrophages and macular degeneration |
| Q42639284 | Macrophages feel their age in macular degeneration. |
| Q37207007 | Macrophages in neovascular age-related macular degeneration: friends or foes? |
| Q33253660 | Macrophages inhibit neovascularization in a murine model of age-related macular degeneration |
| Q39295052 | Macrophages modulate the viability and growth of human mesenchymal stem cells |
| Q42104640 | Macular dysfunction in drusen maculopathy assessed with multifocal electroretinogram and optical coherence tomography |
| Q27000182 | Mechanisms of age-related macular degeneration |
| Q93125757 | Mice With a Combined Deficiency of Superoxide Dismutase 1 (Sod1), DJ-1 (Park7), and Parkin (Prkn) Develop Spontaneous Retinal Degeneration With Aging |
| Q37066074 | Modulation of choroidal neovascularization by subretinal injection of retinal pigment epithelium and polystyrene microbeads. |
| Q37273740 | Molecular pathology of age-related macular degeneration |
| Q46372754 | Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing |
| Q52682224 | Monocyte chemoattractant protein 1 and fractalkine play opposite roles in angiogenesis via recruitment of different macrophage subtypes. |
| Q38189962 | Monocyte subpopulations in angiogenesis. |
| Q33927575 | Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells |
| Q36060689 | Myeloid-Specific Blockade of Notch Signaling Attenuates Choroidal Neovascularization through Compromised Macrophage Infiltration and Polarization in Mice |
| Q35835600 | Myopia and inflammation |
| Q48217093 | New neovascular age-related macular degeneration is associated with systemic leucocyte activity |
| Q40311765 | Nicotine treatment alters NF-kappaB expression in human cytomegalovirus-infected ARPE-19 cells |
| Q42033503 | Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch |
| Q33510137 | Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina |
| Q38074872 | Ocular neovascularization |
| Q92232939 | Optical coherence tomography angiography in uveitis |
| Q35688161 | Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice |
| Q41376252 | Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration |
| Q92001765 | Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells |
| Q55401258 | Oxysterol Signatures Distinguish Age-Related Macular Degeneration from Physiologic Aging. |
| Q41938308 | PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches |
| Q37727943 | Partial recovery of the damaged rat blood-brain barrier is mediated by adherens junction complexes, extracellular matrix remodeling and macrophage infiltration following focal astrocyte loss |
| Q60923720 | Periocular injection of candesartan-PLGA microparticles inhibits laser-induced experimental choroidal neovascularization |
| Q35953670 | Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation |
| Q36230801 | Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina |
| Q38216031 | Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease? |
| Q35557353 | Progress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration |
| Q93000295 | Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment |
| Q42098043 | Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction |
| Q33578980 | Resveratrol regulates pathologic angiogenesis by a eukaryotic elongation factor-2 kinase-regulated pathway |
| Q37194989 | Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy |
| Q38688358 | Roles of exosomes in the normal and diseased eye. |
| Q35968159 | STAT3 Activation in Circulating Monocytes Contributes to Neovascular Age-Related Macular Degeneration |
| Q41441900 | Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model |
| Q33304653 | Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice |
| Q47689628 | Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells |
| Q34253393 | Short-term outcomes of aflibercept for neovascular age-related macular degeneration in eyes previously treated with other vascular endothelial growth factor inhibitors |
| Q35532074 | Short-term outcomes of switching anti-VEGF agents in eyes with treatment-resistant wet AMD. |
| Q36539094 | Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration. |
| Q34113663 | Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344 |
| Q35577903 | Suppression of Laser-Induced Choroidal Neovascularization by the Oral Medicine Targeting Histamine Receptor H4 in Mice. |
| Q28484654 | Suppression of experimental choroidal neovascularization by curcumin in mice |
| Q33225324 | Suppression of laser-induced choroidal neovascularization by oral administration of SA3443 in mice. |
| Q35140051 | Synthesis and propagation of complement C3 by microglia/monocytes in the aging retina |
| Q58713704 | Systemic immunosuppression and risk of age-related macular degeneration |
| Q35736348 | TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration. |
| Q37406558 | Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration |
| Q49834468 | Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old. |
| Q90638487 | Targeting Neuroinflammation in Neovascular Retinal Diseases |
| Q33994168 | Targeting immune privilege to prevent pathogenic neovascularization |
| Q34155901 | Targeting of junctional adhesion molecule-C inhibits experimental choroidal neovascularization |
| Q34442604 | The impact of microglial activation on blood-brain barrier in brain diseases. |
| Q35031349 | The influence of macrophage depletion on ligament healing |
| Q42326687 | The privileged immunity of immune privileged organs: the case of the eye. |
| Q33206080 | The relative contributions of each subset of ocular infiltrated cells in experimental choroidal neovascularisation |
| Q42203980 | The retinal pigment epithelium (RPE) induces FasL and reduces iNOS and Cox2 in primary monocytes |
| Q36954609 | The retinal pigment epithelium as a gateway for monocyte trafficking into the eye. |
| Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
| Q34911490 | The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model |
| Q28085495 | The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity |
| Q92713106 | The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration |
| Q34035522 | Therapeutic effect of oral bisphosphonates on choroidal neovascularization in the human eye. |
| Q39214578 | Therapeutic targets of renin-angiotensin system in ocular disorders |
| Q30496577 | Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction |
| Q35774515 | Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration |
| Q37061531 | Transcriptome Analysis on Monocytes from Patients with Neovascular Age-Related Macular Degeneration |
| Q36083881 | Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex |
| Q35142886 | VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization |
| Q36942812 | Vascular adhesion protein 1 in the eye. |
| Q36804945 | Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. |
| Q37990945 | miRNAs as potential therapeutic targets for age-related macular degeneration. |
Search more.